Become a member of BioTechniques (it's free!) and receive the latest news in the life sciences and member-exclusives.

Ardena announces Commercial Agency Agreement with Keyfronbio

Written by The Nanomed Zone
Nanomedicine News

Belgium-based contract development and manufacturing organization, Ardena (East Flanders, Belgium), has announced the signing of a Commercial Agency Agreement for South Korea with life science company Keyfronbio (Chungcheongbuk-do, South Korea). The biotechnological industry has been recognized as a key economic driver in South Korea and a future engine for growth for the country. Contract development and manufacturing organization Ardena provides pharmaceutical companies with services spanning the drug development landscape – including solid-state research, drug product development and manufacturing and dossier development – to help enable them to bring their molecules to market. Formed in 2011, Keyfronbio is a subsidiary of...

To view this content, please register now for access

Join our member community for FREE to access a collection of journal and online-only features, including:

  • Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
  • The latest news and journal updates delivered straight to your inbox when you want it
  • Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
  • Priority registration to webinars, panel discussions and events
  • Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!